Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study)

Mayo Clinic Proceedings Innovations Quality & Outcomes · Published 2026-07-27 · DOI 10.1016/j.mayocpiqo.2026.100739

Free full text

Authors (31)

Daniells Erazo, Adele Hesters, Gaëlle Bruneteau, Elisa De La Cruz, Emilien Bernard, Aude-Marie Grapperon, Gwendal Le Masson, Pascal Cintas, Marie-Hélène Soriani, Nathalie Guy, Julien Cassereau, Jean-Philippe Camdessanché, Steeve Genestet, Philippe Corcia, Sophie Pittion, Véronique Danel, Mathilde Filliatre, Ariane Choumert, Agnes Jacquin-Piques, François Salachas, Florence Esselin, Adrien Bohic, Géraldine Lautrette, Shahram Attarian, Julie Catteau, Claire Guissart, Marie-Claire Vincent, Kevin Mouzat, Marie Temple, Patrick Vourc’h, Philippe Couratier

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Erazo, D., Hesters, A., Bruneteau, G., et al. (2026). Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study). Mayo Clinic Proceedings Innovations Quality & Outcomes. https://doi.org/10.1016/j.mayocpiqo.2026.100739

Related articles